Illustration of a conditional inference tree for developing RA in pre-symptomatic individuals compared with control subjects. CCP2 anti-CCP2 antibodies, Filaggrin anti-filaggrin antibodies, CEP-1 = anti-α-enolase antibodies, IgM-RF immunoglobulin M rheumatoid factor, HLA-SE human leukocyte antigen shared epitope, n number of individuals, Pr probability of detecting a pre-symptomatic individual, + = positive, − = negative. (DOCX 29 kb
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Figure S1. Agreement between previously determined antibody status and remeasurement by ELISA. Figu...
Clinical features of studied groups of patients with RA and healthy controls. Table S2 The expressio...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
Significant single nucleotide polymorphism (SNP) variants associated with anti-HCP1 positivity in pa...
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
Background: The presence of rheumatoid factor (RF), anti-carbamylated protein antibodies (anti-CarP)...
Supplementary tables and methods. Table S1 Îą-enolase peptide sequences. Table S2 Association betwee...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
Table S1. Disease characteristics (median values) in ACPA reactivity-positive versus reactivity-nega...
Correlations between anti-EBV (left panel), anti-B19 (middle panel), anti-CMV (right panel) IgG leve...
Figure S1. Gating strategy describing T-cell subsets. Figure S2. OPLS-DA score scatter plot showing ...
Baseline characteristics of anti-CCP-2-negative RA patients. Baseline characteristics of anti-CCP-2-...
Prevalence of being positive for different combinations of anti-viral antibodies in RA, ACPA-positiv...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Figure S1. Agreement between previously determined antibody status and remeasurement by ELISA. Figu...
Clinical features of studied groups of patients with RA and healthy controls. Table S2 The expressio...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
Significant single nucleotide polymorphism (SNP) variants associated with anti-HCP1 positivity in pa...
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
Background: The presence of rheumatoid factor (RF), anti-carbamylated protein antibodies (anti-CarP)...
Supplementary tables and methods. Table S1 Îą-enolase peptide sequences. Table S2 Association betwee...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
Table S1. Disease characteristics (median values) in ACPA reactivity-positive versus reactivity-nega...
Correlations between anti-EBV (left panel), anti-B19 (middle panel), anti-CMV (right panel) IgG leve...
Figure S1. Gating strategy describing T-cell subsets. Figure S2. OPLS-DA score scatter plot showing ...
Baseline characteristics of anti-CCP-2-negative RA patients. Baseline characteristics of anti-CCP-2-...
Prevalence of being positive for different combinations of anti-viral antibodies in RA, ACPA-positiv...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Figure S1. Agreement between previously determined antibody status and remeasurement by ELISA. Figu...
Clinical features of studied groups of patients with RA and healthy controls. Table S2 The expressio...